Cardiovascular effects of waterpipe smoking: a systematic review and meta-analysis

doi:10.31083/j.rcm.2020.03.135

Reviews in Cardiovascular Medicine

2020, Vol. 21

Issue (3): 453-468 DOI: 10.31083/j.rcm.2020.03.135

Systematic Review

Previous articles | Next articles

Cardiovascular effects of waterpipe smoking: a systematic review and meta-analysis

Radwan Al Ali^1,^*(

), Davor Vukadinović¹, Wasim Maziak², Lama Katmeh¹, Viktoria Schwarz¹, Felix Mahfoud¹, Ulrich Laufs³, Michael Böhm¹

¹Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University, Kirrberger Str. 100, 66421 Homburg/Saar, Germany
²Robert Stempel College of Public Health, Florida International University, Miami, Florida 33174, USA
³Klinik und Poliklinik für Kardiologie, Universitätsklinikum, Liebigstr. 20, 04103 Leipzig, Germany

Download: PDF(2538KB) ( 889 ) Full text ( 65 )
Export: BibTeX | EndNote (RIS)

Abstract:

Waterpipe smoking has developed into a major and rapidly growing global tobacco epidemic affecting more than 100 million people worldwide. This study identifies and analyzes comprehensively all available data on the cardiovascular effects of waterpipe smoking. Databases PubMed, EMBASE, Web of Science, and the Cochrane Library were searched for studies published until December 2019 assessing cardiovascular effects of waterpipe smoking. We included experimental, cohort, cross-sectional and case-control studies and excluded systematic reviews, case reports/series and qualitative studies. Studies not conducted in humans or not distinguishing waterpipe smoking from other forms of smoking were also excluded. A total of 42 studies with 46 cardiovascular parameters were eligible for analysis. The meta-analysis included 31 studies with 38,037 individuals. Results showed that one waterpipe smoking session leads to immediate increases in heart rate and blood pressure (P $<$ 0.001). Compared to non-smokers, waterpipe smokers had significantly lower high-density lipoprotein levels (P $<$ 0.001), higher levels of low-density lipoprotein (P = 0.04), triglyceride (P $<$ 0.001) and fasting blood glucose (P = 0.03) and higher heart rate (P = 0.04) with a tendency to have higher blood pressure. Mean heart rate, blood pressure and lipids levels did not differ between waterpipe and cigarette smokers, except for total cholesterol, being higher among waterpipe smokers (P $<$ 0.001). Current level of evidence suggests that waterpipe smoking is associated with substantial adverse effects on cardiovascular system, which seem to be similar to those of cigarette smoking. Longitudinal studies are required to scrutinize the magnitude of these effects.

Key words: Waterpipe smoking cardiovascular disease cardiovascular risk factors

Submitted: 14 July 2020 Revised: 09 September 2020 Accepted: 12 September 2020 Published: 30 September 2020

^*Corresponding Author(s): Radwan Al Ali E-mail: radwan.al-ali@uks.eu

	Service
	E-mail this article
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Radwan Al Ali
	Davor Vukadinović
	Wasim Maziak
	Lama Katmeh
	Viktoria Schwarz
	Felix Mahfoud
	Ulrich Laufs
	Michael Böhm

Cite this article:

Radwan Al Ali, Davor Vukadinović, Wasim Maziak, Lama Katmeh, Viktoria Schwarz, Felix Mahfoud, Ulrich Laufs, Michael Böhm. Cardiovascular effects of waterpipe smoking: a systematic review and meta-analysis. Reviews in Cardiovascular Medicine, 2020, 21(3): 453-468.

URL:

https://rcm.imrpress.com/EN/10.31083/j.rcm.2020.03.135 OR https://rcm.imrpress.com/EN/Y2020/V21/I3/453

Fig. 1. PRISMA Flow diagram showing the process of the sytematic search and study selection including eligibility against the inclusion and exclusion criteria. The number of studies is the bottom of the flowchart represents that of the selected studies that were considered eligible for inclusion in this meta-analysis.

Fig. 2. Forest plots demonstrating individual (squares) and pooled (rhombus) acute changes (mean difference) in heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP), with corresponding 95% confidence intervals (horizontal lines), obtained after one waterpipe smoking session. WPS: Waterpipe smoking

Table 1. Study Characteristics.

Study	Study design	Sampling	Participants	N	Male	Age, years Mean $\pm$ SD (range)	WPS			CS	NS	Pre-session abstinence	WPS session, min.	Smoking setting	Tobacco used
Study	Study design	Sampling	Participants	N	Male	Age, years Mean $\pm$ SD (range)	Total	Exclusive	Frequency	CS	NS	Pre-session abstinence	WPS session, min.	Smoking setting	Tobacco used
Experimental studies
Al-Kubati et al., 2006	One-Group Pretest-Posttest	Convenience sampling	Healthy subjects	20	20	27.2 $\pm$ 6.4 (20-40)	20	n.s.	n.s.	-	-	12 h	45	Laboratory	5 g moassal
Alomari et al., 2014	One-Group Pretest-Posttest	Convenience sampling	Healthy subjects	53	34	22.7 $\pm$ 4.8 (18-35)	53	n.s.	$\geq$ 3 WP/week	-	-	n.s.	30	A well-ventilated room	10 g flavoured tobacco
Azar et al., 2016	Three-Group Pretest-Posttest	Convenience sampling	Healthy subjects	194	112	35.6 (> 18)	101	n.s.	n.s.	-	42	12 h	15	Restaurants	n.s.
Bentur et al.,2014	Two-Group Pretest-Posttest	Convenience sampling	Healthy subjects	62	33	24.9 $\pm$ 6.2 ( $\geq$ 18)	47	n.s.	n.s.	-	-	24 h	30	Indoor environment	10 g moassal
Blank et al.,2011	One-Group Pretest-Posttest, Two-condition crossover	Convenience sampling	Healthy subjects	37	29	20.5 $\pm$ 2.1 (18-50)	37	≤ 5 cig/month	2-5 WP/month	-	-	Overnight	45	Laboratory	10 g flavoured tobacco
Cobb et al.,2011	One-Group Pretest-Posttest, Two-condition crossover	Convenience sampling	Healthy subjects	54	36	21.2 $\pm$ 2.3 (18-50)	54	$\geq$ 5 cig/day	$\geq$ 2 WP/month	54	-	12 h	43.3 (CS 6.1)	Laboratory	n.s.
Cobb et al.,2012	One-Group Pretest-Posttest, Two-condition crossover	Convenience sampling	Healthy subjects	32	16	21.6 $\pm$ 2.7 (18-50)	32	≤ 5 cig/month	$\geq$ 4 WP/month	32	-	12 h	45	Laboratory	10 g flavoured tobacco
Eissenberg and Shihadeh,2009	One-Group Pretest-Posttest, Two-condition crossover	Voluntary response sampling	Healthy subjects	31	21	21.4 $\pm$ 2.3 (18-50)	31	$\geq$ 1 cig/week	$\geq$ 1 WP/month	31	-	$\geq$ 12 h	45 (CS 5)	Laboratory	15 g flavoured tobacco
Elias et al.,2012	Two-Group Pretest-Posttest	Convenience sampling	Healthy subjects	100	n.s.	29.5 $\pm$ 10.4 (18-60)	70	70	weekly WPS, (6.9 $\pm$ 3.7)	-	30	n.s.	30	n.s.	n.s.
Hakim et al.,2011	One-Group Pretest-Posttest	Convenience sampling	Healthy subjects	45	30	32.3 $\pm$ 23.4 (18.3-65.1)	45	37	Regularly	-	-	24 h	30	An outdoor environment.	10 g moassal
Hawari et al.,2013	One-Group Pretest-Posttest	Convenience sampling	Healthy subjects	24	24	20.4 (18-25)	24	n.s.	4 (0.5-14) WP/week	-	-	$\geq$ 48 h	45	Laboratory	n.s.
Kadhum et al.,2014	One-Group Pretest-Posttest	Convenience sampling	Healthy subjects	61	49	(18-25)	61	61	n.s.	-	-	$\geq$ 24 h	45-90	Cafes	n.s.
Layoun et al.,2014	Three-Group Pretest-Posttest	Convenience sampling	n.s.	132	87	33.4 ( $\geq$ 18)	42	42	$\geq$ 1WP/week	48	42	n.s.	45	Restaurants	20 g moassal
Nelson et al.,2016	One-Group Pretest-Posttest	Convenience sampling	Healthy subjects	28	20	27 $\pm$ 5 (17-39)	28	28	¿ 12 times in the past year	-	-	72 h	30 (102 $\pm$ 60)	Laboratory	n.s.
Rezk-Hanna et al.,2019	Two-Group Pretest-Posttest	Voluntary response sampling	Healthy subjects	55	10	26 $\pm$ 1 (18-34)	40	40	$\geq$ 12 times in the past year	15	-	Overnight	96 $\pm$ 40 (60-120)	Laboratory	n.s.
Shafagoj and Mohammed,2002	One-Group Pretest-Posttest	Convenience sampling	Healthy subjects	18	18	27 $\pm$ 8 (20-45)	18	18	$\geq$ 3 times/week	-	-	84 h	45	Laboratory	20 g moassal
Shaikh et al.,2008	One-Group Pretest-Posttest	Cluster sampling	Healthy subjects	202	202	33.2 (¿ 17)	202	202	n.s.	-	-	20 min	30-45	Café	n.s.
Shishani et al.,2014	One-Group Pretest-Posttest Two-condition crossover	Voluntary response sampling	Healthy subjects	22	n.s.	23 $\pm$ 3.1 (18-30)	22	22	$\geq$ 10 times in the past year, and ≤ 2 times/week in the past 3 months	-	-	24 h	45–60	Outdoor laboratory	n.s.
Wolfram et al.,2003	One-Group Pretest-Posttest	Convenience sampling	Healthy subjects	7	7	$\geq$ 18	7	7	occasionally	-	-	3 months	55 (45-70)	Laboratory	15 g of tobacco
Case-control studies
Al-Amri et al.,2019	Case-control hospital-based	Convenience sampling	Cases are myocardial infarction, controls from dermatology and surgery departments	296	203	47.8 $\pm$ 14.6 ( $\geq$ 18)	35	35	Daily	89	261	n.s.	-	-	n.s.
Al-Numair et al.,2007	Case-control	Convenience sampling	Healthy subjects	200	200	(19-50)	100	100	Daily	-	100	n.s.	-	-	ma’ssel
Chami et al.,2019	Case-control community-based	Convenience and voluntary response sampling	Healthy subjects	345	233	53.7 $\pm$ 9.1 ( $\geq$ 35)	175	98%	Daily	-	170	n.s.	-	-	n.s.
Chwyeed,2018	Case-control	Randomly selection	Healthy subjects	75	75	(30-60)	20	20	n.s.	20	35	n.s.	-	-	n.s.
Diab et al.,2015	Case-control	Convenience sampling	Healthy subjects	77	77	35.1 $\pm$ 1.05 (≤ 60)	30	30	Daily	30	17	n.s.	-	-	n.s.
Ghasemi et al.,2010	Case-control community-based	Convenience sampling	Healthy subjects	54	54	33.3 $\pm$ 2.94	27	27	Daily	-	27	n.s.	-	-	mostly of moassal
Hashem Sezavar et al.,2004	Case-control community-based	Convenience sampling	n.s.	450	450	(20-75)	150	150	Daily	150	150	n.s.	-	-	n.s.
Jabbour et al.,2003	Case-control hospital-based	Convenience sampling	Cases are CHD patients, controls recruited from 3 hospitals	525	n.s.	n.s.	49	n.s.	¿ 4/week	-	299	n.s.	-	-	n.s.
Koubaa et al.,2015a	Case-control community-based	Convenience sampling	Healthy subjects	43	43	43.6 $\pm$ 2.2	14	14	$\geq$ 5 WP-year	15	14	n.s.	-	-	10 and 25 g
Koubaa et al.,2015b	Case-control community-based	Convenience sampling	Healthy subjects	43	43	43.6 $\pm$ 2.2	14	14	$\geq$ 5 WP-year	15	14	n.s.	-	-	10 and 25 g
Muddathir et al.,2018	Case-control	Convenience sampling	Healthy subjects	120	80	29.2 (18-51)	40	40	Daily	40	40	n.s.	-	-	n.s.
Selim et al.,2013a	Case-control community-based	Convenience sampling	Healthy subjects	70	63	28.7 (25-35)	30	30	Daily	30	10	n.s.	-	-	n.s.
Cross-sectional/cohort studies
Al Suwaidi et al.,2012	Cross-sectional prospective hospital-based cohort	Convenience sampling	ACS patients	7930	6253	59.6	130	130	Regular	3605	3742	-	-	-	n.s.
Al-Safi et al.,2009	Cross-sectional population-based	Stratified cluster random sampling	Healthy subjects	14310	7400	31.4 ( $\geq$ 18)	2272	1132	$\geq$ 1 WP/week	2691	9347	n.s.	-	-	n.s.
Islami et al.,2013	Cross-sectional prospective population-based cohort	Systematic clustering random sampling	Cases: participants with heart disease history, Controls: participants with no heart disease history	50045	21234	(40-75)	525	n.s.	Ever	-	49489	n.s.	-	-	n.s.
Khan et al.,2020	Cross-sectional community-based	Voluntary response sampling	Healthy subjects	73	41	39.8 (21-65)	12	12	Daily	26	25	n.s.	-	-	n.s.
	Cross-sectional community-based	Voluntary response sampling	Healthy subjects	57	27	25.4	33	33	$\geq$ 1 WP/month		24	n.s.	-	-	n.s.
Platt et al.,2017	Cross-sectional hospital-based	Convenience sampling	Coronary angiography patients	7705	5188	61.2 $\pm$ 11.4	574	574	Regularly	2625	4506	n.s.	-	-	n.s.
Saffar Soflaei et al.,2018	Cross-sectional population-based	Stratified cluster random sampling	-	9690	n.s.	(35-65)	1067	1067	n.s.	864	6742	n.s.	-	-	n.s.
Selim et al.,2013b	Cross-sectional hospital-based	Convenience sampling	Coronary angiography patients	287	n.s.	n.s.	63	63	Regularly	100	109	n.s.	-	-	n.s.
Shafique et al.,2012	Cross-sectional population-based cohort	Voluntary response sampling	Healthy subjects	2032	1039	(30-75)	325	325	$\geq$ 1 WP/week	-	1707	n.s.	-	-	n.s.
Sibai et al.,2014	Cross-sectional hospital-based	Convenience sampling	Coronary angiography patients	1754	n.s.	( $\geq$ 40)	235	n.s.	Ever $\geq$ 1 WP-year	544	975	n.s.	-	-	n.s.
Ward et al.,2015	Cross-sectional population-based	Stratified cluster random sampling	-	2536	1220	25-65	286	n.s.	Regularly	-	2134	n.s.	-	-	n.s.
Wu et al.,2013	Cross-sectional prospective population-based cohort	Convenience sampling	n.s.	20033	1971	(18-75)	n.s.	n.s.	Ever regularly	n.s.	n.s.	n.s.	-	-	n.s.
WP: Waterpipe, WPS: Waterpipe smoking, CS: Cigarette smoking, ACS: Acute coronary syndrome. CHD: Coronary heart disease. n.s.: Not specified.

Fig. 3. Forest plots demonstrating individual (squares) and pooled (rhombus) mean differences in heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP), with corresponding 95% confidence intervals (horizontal lines), obtained in waterpipe smokers compared to non-smokers. WPS: Waterpipe smoking. NS: Non-smoking.

Fig. 4. Forest plots demonstrating individual (squares) and pooled (rhombus) mean differences in blood levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL) and triglyceride (TG), with corresponding 95% confidence intervals (horizontal lines), obtained in waterpipe smokers compared to non-smokers. WPS: Waterpipe smoking. NS: Non-smoking.

Fig. 5. Forest plots demonstrating individual (squares) and pooled (rhombus) mean differences in heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP), with corresponding 95% confidence intervals (horizontal lines), obtained in waterpipe smokers compared to cigarette smokers. WPS: Waterpipe smoking. CS: Cigarette smoking.

Fig. 6. Forest plots demonstrating individual (squares) and pooled (rhombus) mean differences in blood levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL) and triglyceride (TG), with corresponding 95% confidence intervals (horizontal lines), obtained in waterpipe smokers compared to cigarette smokers. WPS: Waterpipe smoking. CS: Cigarette smoking.

[1]	Al-Amri, A., Ghalilah, K., Al-Harbi, A., Al-Dubai, S. A. R., Al-Ghamdi, S. and Al-Zalabani, A. (2019) Waterpipe smoking and the risk of myocardial infarction: a hospital-based case-control study. Tobacco Induced Diseases 17, 87-87.
[2]	Al-Kubati, M., Al-Kubati, A. S., al’Absi, M. and Fišer, B. (2006) The short-term effect of water-pipe smoking on the baroreflex control of heart rate in normotensives. Autonomic Neuroscience 126-127, 146-149.
[3]	Al-Numair, K., Barber-Heidal, K., Al-Assaf, A. and El-Desoky, G. (2007) Water-pipe (shisha) smoking influences total antioxidant capacity and oxidative stress of healthy saudi males. Journal of Food Agriculture and Environment 5, 17-22.
[4]	Al-Safi, S. A., Ayoub, N. M., Albalas, M. A., Al-Doghim, I. and Aboul-Enein, F. H. (2009) Does shisha smoking affect blood pressure and heart rate? Journal of Public Health 17, 121-126.
[5]	Al Suwaidi, J., Al Habib, K., Singh, R., Hersi, A., Al Nemer, K., Asaad, N., Al Saif, S., Al-Motarreb, A., Almahmeed, W., Sulaiman, K., Amin, H., Al-Lawati, J., Al Bustani, N., Al-Sagheer, N. Q. and Ali, W. M. (2012) Tobacco modalities used and outcome in patients with acute coronary syndrome: an observational report. Postgraduate Medical Journal 88, 566-574.
[6]	Alomari, M. A., Khabour, O. F., Alzoubi, K. H., Shqair, D. M. and Eissenberg, T. (2014) Central and peripheral cardiovascular changes immediately after waterpipe smoking. Inhalation Toxicology 26, 579-587.
[7]	Ambrose, J. A. and Barua, R. S. (2004) The pathophysiology of cigarette smoking and cardiovascular disease. Journal of the American College of Cardiology 43, 1731-1737.
[8]	Azar, R. R., Frangieh, A. H., Mroué, J., Bassila, L., Kasty, M., Hage, G. and Kadri, Z. (2016) Acute effects of waterpipe smoking on blood pressure and heart rate: a real-life trial. Inhalation Toxicology 28, 339-342.
[9]	Benowitz, N. L. (2003) Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Progress in Cardiovascular Diseases 46, 91-111.
[10]	Bentur, L., Hellou, E., Goldbart, A., Pillar, G., Monovich, E., Salameh, M., Scherb, I. and Bentur, Y. (2014) Laboratory and clinical acute effects of active and passive indoor group water-pipe (narghile) smoking. Chest 145, 803-809.
[11]	Blank, M. D., Cobb, C. O., Kilgalen, B., Austin, J., Weaver, M. F., Shihadeh, A. and Eissenberg, T. (2011) Acute effects of waterpipe tobacco smoking: a double-blind, placebo-control study. Drug and Alcohol Dependence 116, 102-109.
[12]	Chami, H. A., Isma’eel, H., Tamim, H., Adawi, M., Al Kuwari, M. and Al Mullah, A. (2019) The association of water-pipe smoking and coronary artery calcium in a community-based sample. Chest 155, 1217-1225.
[13]	Chwyeed, S. (2018) A Comparison between the Effect of Shisha and Cigarette Smoking on Serum Lipid Profile of Males in Nasiriyah City. Medical Journal of Babylon 15, 39-42.
[14]	Cobb, C. O., Sahmarani, K., Eissenberg, T. and Shihadeh, A. (2012) Acute toxicant exposure and cardiac autonomic dysfunction from smoking a single narghile waterpipe with tobacco and with a “healthy” tobacco-free alternative. Toxicology Letters 215, 70-75.
[15]	Cobb, C. O., Shihadeh, A., Weaver, M. F. and Eissenberg, T. (2011) Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effects. Nicotine & Tobacco Research 13, 78-87.
[16]	Diab, O. A., Abdelrahim, E. M. and Esmail, M. (2015) Effect of water pipe tobacco smoking on plasma high sensitivity C reactive protein level and endothelial function compared to cigarette smoking. The Egyptian Heart Journal 67, 233-241.
[17]	Eissenberg, T. and Shihadeh, A. (2009) Waterpipe tobacco and cigarette smoking. American Journal of Preventive Medicine 37, 518-523.
[18]	Elias, W., Assy, N., Elias, I., Toledo, T., Yassin, M. and Bowirrat, A. (2012) The detrimental danger of water-pipe (Hookah) transcends the hazardous consequences of general health to the driving behavior. Journal of Translational Medicine 10, 126.
[19]	Eliasson, M. (1995) Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA study. Atherosclerosis 113, 41-53.
[20]	El-Zaatari, Z. M., Chami, H. A. and Zaatari, G. S. (2015) Health effects associated with waterpipe smoking. Tobacco Control 24, i31-i43.
[21]	Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A. and Rahimi, K. (2016) Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. the Lancet 387, 957-967.
[22]	Ghasemi, A., Syedmoradi, L., Momenan, A. A., Zahediasl, S. and Azizi, F. (2010) The influence of cigarette and qalyan (hookah) smoking on serum nitric oxide metabolite concentration. Scandinavian Journal of Clinical and Laboratory Investigation 70, 116-121.
[23]	Hakim, F., Hellou, E., Goldbart, A., Katz, R., Bentur, Y. and Bentur, L. (2011) The acute effects of water-pipe smoking on the cardiorespiratory system. Chest 139, 775-781.
[24]	Hammal, F., Chappell, A., Wild, T. C., Kindzierski, W., Shihadeh, A., Vanderhoek, A., Huynh, C. K., Plateel, G. and Finegan, B. A. (2015) ’Herbal’ but potentially hazardous: an analysis of the constituents and smoke emissions of tobacco-free waterpipe products and the air quality in the cafes where they are served. Tobacco Control 24, 290-297.
[25]	Hashem Sezavar, S., Abedi, A. and Sadeghi Bazargani, H. (2004) A comparative study of plasma fibrinogen among hookah smokers, cigarette smokers and non-smokers. Iranian Heart Journal 5, 48-54.
[26]	Hawari, F. I., Obeidat, N. A., Ayub, H., Ghonimat, I., Eissenberg, T., Dawahrah, S. and Beano, H. (2013) The acute effects of waterpipe smoking on lung function and exercise capacity in a pilot study of healthy participants. Inhalation Toxicology 25, 492-497.
[27]	Islami, F., Pourshams, A., Vedanthan, R., Poustchi, H., Kamangar, F., Golozar, A., Etemadi, A., Khademi, H., Freedman, N. D., Merat, S., Garg, V., Fuster, V., Wakefield, J., Dawsey, S. M., Pharoah, P., Brennan, P., Abnet, C. C., Malekzadeh, R. and Boffetta, P. (2013) Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran. Heart 99, 272-278.
[28]	Jabbour, S., El-Roueiheb, Z. and Sibai, A. M. (2003) Nargileh (Water-Pipe) smoking and incident coronary heart disease: a case-control study. Annals of Epidemiology 13, 570.
[29]	Kadhum, M., Jaffery, A., Haq, A., Bacon, J. and Madden, B. (2014) Measuring the acute cardiovascular effects of shisha smoking: a cross-sectional study. JRSM Open 5, 205427041453112.
[30]	Khan, N. A., Lawyer, G., McDonough, S., Wang, Q., Kassem, N. O., Kas-Petrus, F., Ye, D., Singh, K. P., Kassem, N. O. and Rahman, I. (2020) Systemic biomarkers of inflammation, oxidative stress and tissue injury and repair among waterpipe, cigarette and dual tobacco smokers. Tobacco Control 29, s102-s109.
[31]	Koubaa, A., Triki, M., Trabelsi, H., Masmoudi, L., Sahnoun, Z. and Hakim, A. (2015a) Changes in antioxidant defense capability and lipid profile after 12-week low- intensity continuous training in both cigarette and hookah smokers: a follow-up study. PLoS One 10, e0130563.
[32]	Koubaa, A., Triki, M., Trabelsi, H., Masmoudi, L., Zeghal, K. N., Sahnoun, Z. and Hakim, A. (2015b) Effect of low-intensity continuous training on lung function and cardiorespiratory fitness in both cigarette and hookah smokers. African Health Sciences 15, 1170-1181.
[33]	Layoun, N., Saleh, N., Barbour, B., Awada, S., Rachidi, S., Al-Hajje, A., Bawab, W., Waked, M. and Salameh, P. (2014) Waterpipe effects on pulmonary function and cardiovascular indices: a comparison to cigarette smoking in real life situation. Inhalation Toxicology 26, 620-627.
[34]	Leone, A. (2003) Relationship between cigarette smoking and other coronary risk factors in atherosclerosis: risk of cardiovascular disease and preventive measures. Current Pharmaceutical Design 9, 2417-2423.
[35]	Marshall, M., Ghazipura, M., Hossain, T., Gordon, T. and Chen, L. (2018) Cardiopulmonary risk of waterpipe smoke: a meta-analysis. Journal of Lung Health and Diseases 2, 31-40.
[36]	Maziak, W., Taleb, Z. B., Bahelah, R., Islam, F., Jaber, R., Auf, R. and Salloum, R. G. (2015) The global epidemiology of waterpipe smoking. Tobacco Control 24, i3-i12.
[37]	Mons, U., Muezzinler, A., Gellert, C., Schottker, B., Abnet, C. C., Bobak, M., de Groot, L., Freedman, N. D., Jansen, E., Kee, F., Kromhout, D., Kuulasmaa, K., Laatikainen, T., O’Doherty, M. G., Bueno-de-Mesquita, B., Orfanos, P., Peters, A., van der Schouw, Y. T., Wilsgaard, T., Wolk, A., Trichopoulou, A., Boffetta, P., Brenner, H. and on behalf of the CHANCES consortium (2015) Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ 350, h1551-h1551.
[38]	Muddathir, A., Abd Alla, M. and Khabour, O. (2018) Waterpipe Smoking is associated with changes in fibrinogen, FVII, and FVIII levels. Acta Haematologica 140, 159-165.
[39]	Nelson, M. D., Rezk-Hanna, M., Rader, F., Mason, O. R., Tang, X., Shidban, S., Rosenberry, R., Benowitz, N. L., Tashkin, D. P., Elashoff, R. M., Lindner, J. R. and Victor, R. G. (2016) Acute effect of hookah smoking on the human coronary microcirculation. The American Journal of Cardiology 117, 1747-1754.
[40]	Nikolovska Vukadinović, A., Vukadinović, D., Borer, J., Cowie, M., Komajda, M., Lainscak, M., Swedberg, K. and Böhm, M. (2017) Heart rate and its reduction in chronic heart failure and beyond. European Journal of Heart Failure 19, 1230-1241.
[41]	Patsopoulos, N. A., Evangelou, E. and Ioannidis, J. P. (2008) Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. International Journal of Epidemiology 37, 1148-1157.
[42]	Pedro-Botet, J., Ascaso, J. F., Blasco, M., Brea, Á., Díaz, Á., Hernández-Mijares, A, Pintó, X., Millán, J., Grupo de trabajo sobre Dislipidemia Aterogénica and Sociedad Española de Arteriosclerosis. (2020) Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias. Clínica e Investigación en Arteriosclerosis (in press).
[43]	Platt, D. E., Hariri, E., Salameh, P., Helou, M., Sabbah, N., Merhi, M., Chammas, E., Ammar, W., Abchee, A. B. and Zalloua, P. A. (2017) Association of waterpipe smoking with myocardial infarction and determinants of metabolic syndrome among catheterized patients. Inhalation Toxicology 29, 429-434.
[44]	Rezk-Hanna, M. and Benowitz, N. L. (2019a) Cardiovascular effects of hookah smoking: potential implications for cardiovascular risk. Nicotine and Tobacco Research 21, 1151-1161.
[45]	Rezk-Hanna, M., Mosenifar, Z., Benowitz, N. L., Rader, F., Rashid, M., Davoren, K., Moy, N. B., Doering, L., Robbins, W., Sarna, L., Li, N., Chang, L. C., Elashoff, R. M. and Victor, R. G. (2019b) High carbon monoxide levels from charcoal combustion mask acute endothelial dysfunction induced by hookah (waterpipe) smoking in young adults. Circulation 139, 2215-2224.
[46]	Saffar Soflaei, S., Darroudi, S., Tayefi, M., Nosrati Tirkani, A., Moohebati, M., Ebrahimi, M., Esmaily, H., Parizadeh, S. M. R., Heidari-Bakavoli, A. R., Ferns, G. A. and Ghayour-Mobarhan, M. (2018) Hookah smoking is strongly associated with diabetes mellitus, metabolic syndrome and obesity: a population-based study. Diabetology and Metabolic Syndrome 10, 33.
[47]	Salahuddin, S., Prabhakaran, D. and Roy, A. (2012) Pathophysiological mechanisms of tobacco-related CVD. Global Heart 7, 113.
[48]	Selim, G. M., Elia, R. Z., El Bohey, A. S. and El Meniawy, K. A. (2013a) Effect of shisha vs. cigarette smoking on endothelial function by brachial artery duplex ultrasonography: an observational study. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology 13, 759-765.
[49]	Selim, G. M., Fouad, H. and Ezzat, S. (2013b) Impact of shisha smoking on the extent of coronary artery disease in patients referred for coronary angiography. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology 13, 647-654.
[50]	Shafagoj, Y. A. and Mohammed, F. I. (2002) Levels of maximum end-expiratory carbon monoxide and certain cardiovascular parameters following hubble-bubble smoking. Saudi Medical Journal 23, 953-958.
[51]	Shafique, K., Mirza, S. S., Mughal, M. K., Arain, Z. I., Khan, N. A., Tareen, M. F. and Ahmad, I. (2012) Water-Pipe smoking and metabolic syndrome: a population-based study. PLoS One 7, e39734.
[52]	Shaikh, R. B., Vijayaraghavan, N., Sulaiman, A. S., Kazi, S. and Shafi, M. S. (2008) The acute effects of waterpipe smoking on the cardiovascular and respiratory systems. Journal of Preventive Medicine and Hygiene 49, 101-107.
[53]	Shihadeh, A. (2003) Investigation of mainstream smoke aerosol of the argileh water pipe. Food and Chemical Toxicology 41, 143-152.
[54]	Shishani, K., Howell, D., McPherson, S. and Roll, J. (2014) Young adult waterpipe smokers: Smoking behaviors and associated subjective and physiological effects. Addictive Behaviors 39, 1113-1119.
[55]	Sibai, A. M., Tohme, R. A., Almedawar, M. M., Itani, T., Yassine, S. I., Nohra, E. A. and Isma’eel, H. A. (2014) Lifetime cumulative exposure to waterpipe smoking is associated with coronary artery disease. Atherosclerosis 234, 454-460.
[56]	Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355, i4919.
[57]	Vigo, D. E., Pérez Lloret, S., Videla, A. J., Pérez Chada, D., Hünicken, H. M., Mercuri, J., Romero, R., Nicola Siri, L. C. and Cardinali, D. P. (2010) Heart rate nonlinear dynamics during sudden hypoxia at 8230 m simulated altitude. Wilderness and Environmental Medicine 21, 4-10.
[58]	Ward, K. D., Ahn, S., Mzayek, F., Al Ali, R., Rastam, S., Asfar, T., Fouad, F. and Maziak, W. (2015) The relationship between waterpipe smoking and body weight: population-based findings from Syria. Nicotine and Tobacco Research 17, 34-40.
[59]	Waziry, R., Jawad, M., Ballout, R. A., Al Akel, M. and Akl, E. A. (2018) The effects of waterpipe tobacco smoking on health outcomes: an updated systematic review and meta-analysis. International Journal of Epidemiology 46, 32-43.
[60]	Wolfram, R. M., Chehne, F., Oguogho, A. and Sinzinger, H. (2003) Narghile (water pipe) smoking influences platelet function and (iso-)eicosanoids. Life Sciences 74, 47-53.
[61]	Wu, F., Chen, Y., Parvez, F., Segers, S., Argos, M., Islam, T., Ahmed, A., Rakibuz-Zaman, M., Hasan, R., Sarwar, G. and Ahsan, H. (2013) A prospective study of tobacco smoking and mortality in bangladesh. PLoS One 8, e58516.

[1]	Shanna J. Hardin, Mahavir Singh, Wintana Eyob, Jack C. Molnar, Rubens P. Homme, Akash K. George, Suresh C. Tyagi. Diet-induced chronic syndrome, metabolically transformed trimethylamine-N-oxide, and the cardiovascular functions[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 121-128.
[2]	Wenyan Jiang, Mei Wang. New insights into the immunomodulatory role of exosomes in cardiovascular disease[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 153-160.
[3]	Rudaynah A. Alali. A short review of proprotein convertase subtilisin/kexin type 9 inhibitors[J]. Reviews in Cardiovascular Medicine, 2019, 20(1): 1-8.
[4]	Jennifer G. Robinson, Karol E. Watson. Identifying Patients for Nonstatin Therapy[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 1-8.
[5]	Davide Bolignano, Anna Pisano, Graziella D’Arrigo. Pulmonary hypertension: a neglected risk condition in renal patients?[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 117-121.
[6]	Peter A. McCullough, Aaron Y. Kluger, Kristen M. Tecson, Clay M. Barbin, Andy Y. Lee, Edgar V. Lerma, Zachary P. Rosol, Sivan L. Kluger, Janani Rangaswami. Inhibition of the Sodium–Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2[J]. Reviews in Cardiovascular Medicine, 2018, 19(2): 51-63.
[7]	Alberto Palazzuoli, Helen Hashemi, Lauren C. Jameson, Peter A. McCullough. Hyperuricemia and Cardiovascular Disease[J]. Reviews in Cardiovascular Medicine, 2017, 18(4): 134-145.
[8]	Claudio Ronco, Federico Ronco, Peter A. McCullough. A Call to Action to Develop Integrated Curricula in Cardiorenal Medicine[J]. Reviews in Cardiovascular Medicine, 2017, 18(3): 93-99.
[9]	Boback Ziaeian, John Dinkler, Karol Watson. Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 125-130.
[10]	Norman E. Lepor, Dean D. Fouchia, Peter A. McCulloughsup. New Vistas for the Treatment of Obesity: Turning the Tide Against the Leading Cause of Morbidity and Cardiovascular Mortality in the Developed World[J]. Reviews in Cardiovascular Medicine, 2014, 15(S2): 1-21.
[11]	Virginia A. Triant. Epidemiology of Coronary Heart Disease in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 1-8.
[12]	Patrick W.G. Mallon. Impact of Nucleoside Reverse Transcriptase Inhibitors on Coronary Heart Disease[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 21-29.
[13]	Norman E. Lepor, Laurn Contreras, Chirag Desai, Dean J. Kereiakes. The Potential Role of Anti-PCSK9 Monoclonal Antibodies in the Management of Hypercholesterolemia[J]. Reviews in Cardiovascular Medicine, 2014, 15(4): 290-309.
[14]	Karol E. Watson, Eric H. Stocker, Douglas S. Jacoby, Peter A. McCullough. Advanced Lipid Testing: When, Why, and In Whom?[J]. Reviews in Cardiovascular Medicine, 2014, 15(4): 310-319.
[15]	Sabas I. Gomez, Pablo Urbandt, Nirat Beohar, Orlando Santana. Renal Denervation: Current Status and Future Applications[J]. Reviews in Cardiovascular Medicine, 2014, 15(4): 351-357.

No Suggested Reading articles found!

Viewed

Full text

Abstract

Cited

Shared

Discussed

Home

About

Articles

Special issues

For authors

For reviewers

Alerts

Contact us

Cite this article:

URL: